Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 203
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Weekly Psychedelic Policy Briefing, September 21, 2026
Health Canada Authorizes Optimi’s Natural Psilocybin Trial as House Bill Targets Botanical Drug Exclusivity
Pα+ Psychedelic Bulletin #232: Q2’26 Psychedelic Lobbying Update; DEA Again Moves to Schedule 5 Tryptamines; Oregon Backpedals Psilocybin Fee Hike
Podcast: Psychedelics in D.C., FDA’s Framework, and New Zealand’s MDMA Prescribers
Introducing The Psychedelic News Feed Podcast
Field Trip Health and Cerebral Partner to Provide End-to-End Mental Health...
PT297 – Laura Mae Northrup, LMFT – Radical Healership in a...
Psychedelic Bulletin: Following the Money – How Much do Psychedelics Companies...
HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive...
Lobe Sciences Ltd. Strengthens Its Balance Sheet
Entheon Biomedical Announces EBIQ-101 First-Patient Dose
COMPASS Pathways announces financial results for the fourth quarter and full...
MindMed Converts Multiple Voting Shares to Subordinate Voting Shares
PharmaDrug Receives Positive Results for DMT-Analogue Program to Treat Glaucoma
Filament Health and ATMA Journey Centers Announce Licensing Agreement
Load more